INmune Bio Inc.

NASDAQ: INMB · Real-Time Price · USD
2.53
0.08 (3.27%)
At close: Aug 15, 2025, 3:59 PM
2.47
-2.37%
After-hours: Aug 15, 2025, 07:51 PM EDT

INmune Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
14K 155K 374K 181K
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
14K 155K 374K 181K
Operating Income
-42.63M -29.74M -25.95M -29.15M
Interest Income
n/a n/a n/a n/a
Pretax Income
-42.08M -30.01M -27.3M -30.34M
Net Income
-42.08M -30.01M -27.3M -30.34M
Selling & General & Admin
9.48M 9.62M 9.26M 8.79M
Research & Development
33.17M 20.27M 17.07M 20.54M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
42.65M 29.9M 26.32M 29.33M
Interest Expense
n/a n/a 1.35M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
42.65M 29.9M 26.32M 29.33M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
19.94M 17.98M 17.93M 16.13M
Shares Outstanding (Diluted)
19.94M 17.98M 17.93M 16.13M
EPS (Basic)
-2.11 -1.67 -1.52 -1.88
EPS (Diluted)
-2.11 -1.67 -1.52 -1.88
EBITDA
-42.08M -29.74M -25.95M -29.15M
EBIT
-42.63M -29.74M -25.95M -29.15M
Depreciation & Amortization
553K 29.74M 25.95M 29.15M